Our sponsors’ committment to World Alzheimer’s Month

We asked some of our sponsors what inspires them to support World Alzheimer's Month as well as people living with dementia and their families.

We would not be able to carry out the work that we do each World Alzheimer’s Month without the generosity of our sponsors.

This past September, we asked some of our sponsors what inspires them to support people living with dementia and their families, as well as the World Alzheimer’s Month campaign.

Nikki Bayliss, Head of Development, said: “At a time when access to diagnosis remains the exception rather than the norm for people living with dementia, ADI knows that collectively we must do more and act now to ensure that care, treatment and support is available to all those who need it. World Alzheimer’s Month is a brilliant platform for ADI to focus on the most pertinent issues affecting the dementia community globally, and we are incredibly proud to reach many millions of people every year with our messages. We are honoured to work with many fantastic sponsors who so generously support our campaign and without whom we could not achieve such success.

Like us, they know that people living with dementia and their families deserve better, and are  committed to driving forward progress with treatments, technologies, education, care and support. Their engagement with World Alzheimer’s Month goes far beyond financial support and we are delighted to see so many sponsors lending their voices to the campaign this year. Our spirit of collaboration truly demonstrates that together, we can do so much.


Laura Campo, Senior Director International Corporate Affairs, Lilly said: 

“At Lilly, patients and loved ones are at the centre of everything we do. For over 30 years, Lilly has been dedicated to researching Alzheimer’s and helping to create a better future for people living with this devastating disease. This is why we want to take an active role during World Alzheimer’s Month and join forces with patients’ associations, people living with dementia, their families and other organisations in calling for dementia to be a global health priority. Obtaining a timely clinical and accurate pathological diagnosis can provide patients a better chance to benefit from treatments, manage co-morbid conditions, offer the opportunity to participate in clinical trials, and help patients and families plan for the future. We are proud to support this year’s campaign.”


“In fulfilling our human health care (hhc) mission of putting patients and their families first, Eisai has dedicated four decades of work to Alzheimer’s disease research and development, with the goal of bringing hope through the relentless pursuit of solutions for patients, their families, and the healthcare professionals who serve them. We are proud to support World Alzheimer’s Month and the ongoing initiatives to educate and raise awareness for people living with Alzheimer’s disease and their families.”


Emil Peters, Tunstall CEO, said:

I’m incredibly proud that we’ve been able to form this partnership with ADI. Cases of dementia are increasing fast, which is why we’re passionate about using our expertise to advance digital care and health solutions. It’s so important that people have the choice for how and where they live their life, regardless of any physical or neurological health issues. Advancements in healthcare technology have the power to give people that choice.

“Tunstall believe that technology has the power to enable people living with dementia to receive the best care without limiting their quality of life and independence. We have employees around the world in countries including the UK, Denmark, Sweden, France, Germany, Spain, all working with technologies to help people affected by dementia to live the fullest life possible.

Read more related content


Information about contributors and funders to ADI, including our corporate partners, trusts, foundations, companies and individuals that support us. Read More